Bruce M Hendry

8PUBLICATIONS
22CO-AUTHORS
Innate immunityCross-sectional analysisMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 22, 2025
Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy.

Hiddo J L Heerspink, Brad H Rovin, Radko Komers

|Sep 21, 2024
Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis.

Zheng-Yi Zhou, Mark E Bensink, Nisha C Hazra

|Apr 13, 2023
Long-Term Outcomes in IgA Nephropathy.

David Pitcher, Fiona Braddon, Bruce Hendry

|May 21, 2020
Ion-Channel modulator TH1177 reduces glomerular injury and serum creatinine in chronic mesangial proliferative disease in rats.

Andrea Cove-Smith, Claire C Sharpe, Michael J Shattock

|Oct 02, 2019
Inhibition of Kirsten-Ras reduces fibrosis and protects against renal dysfunction in a mouse model of chronic folic acid nephropathy.

Lucy J Newbury, Jui-Hui Wang, Gene Hung

Pageof 2

Frequent Collaborators

4 joint publications

Alex Mercer

3 joint publications

David Pitcher

3 joint publications

Retha Steenkamp

2 joint publications

Fiona Braddon